MolDX: Plasma-Based Genomic Profiling in Solid Tumors (L39232) - R1 - Effective March 6, 2025

Date Posted: March 7, 2025

This MolDX Local Coverage Determination (LCD) has been revised under contractor numbers: 02102 (AK), 02202 (ID), 02302 (OR), 02402 (WA), 03102 (AZ), 03202 (MT), 03302 (ND), 03402 (SD), 03502 (UT), and 03602 (WY).

Effective Date: March 6, 2025

Summary of Changes:

Under Coverage Indications, Limitations, and/or Medical Necessity subheading Criteria for Coverage 7th bullet revised "NSLC" to "NSCLC". Under Bibliography changes were made to citations to reflect AMA citation guidelines. Formatting and punctuation were corrected throughout the LCD. This revision is effective on 03/06/2025.

Visit the Noridian Molecular Diagnostic Services webpage to view the Active MolDX LCD or access it via the CMS Medicare Coverage Database (MCD).

Last Updated Mar 07 , 2025